A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of this study is to assess the efficacy and safety of nipocalimab in reducing the risk of severe fetal and neonatal alloimmune thrombocytopenia (FNAIT).
Epistemonikos ID: 553e081a41d8b879006d993797c6b8c65e154426
First added on: Sep 01, 2024